ADJUVANT CHEMOTHERAPY IN STAGE-II BREAST-CANCER

被引：0
|
作者：
RIVKIN, S
GLUCKSBERG, H
RASMUSSEN, S
机构：
[1] SWEDISH HOSP,INST TUMOR,SEATTLE,WA 98104
[2] UNIV WASHINGTON,SEATTLE,WA 98195
[3] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,HOUSTON,TX 77030
[4] SW ONCOL GRP,KANSAS CITY,KS 66103
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1979年 / 20卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：353 / 353
页数：1
相关论文
共 50 条
  • [41] STAGE-II BREAST-CANCER IS NOT SIMPLY A LATE STAGE-I
    MUELLER, CB
    [J]. SURGERY, 1988, 104 (04) : 631 - 638
  • [42] BREAST-CONSERVING SURGERY AND SELECTIVE ADJUVANT RADIATION-THERAPY FOR STAGE-I AND STAGE-II BREAST-CANCER
    MOFFAT, FL
    KETCHAM, AS
    [J]. SEMINARS IN SURGICAL ONCOLOGY, 1992, 8 (03): : 172 - 176
  • [43] PROGESTERONE RECEPTORS AS A PROGNOSTIC FACTOR IN STAGE-II BREAST-CANCER
    GORDON, NH
    HUBAY, CA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (20): : 1325 - 1325
  • [44] PROGESTERONE RECEPTORS AS A PROGNOSTIC FACTOR IN STAGE-II BREAST-CANCER
    CLARK, GM
    MCGUIRE, WL
    HUBAY, CA
    PEARSON, OH
    MARSHALL, JS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (22): : 1343 - 1347
  • [45] LATE RELAPSE AFTER ADJUVANT CHEMOTHERAPY FOR STAGE-II TESTICULAR CANCER
    WEISS, RB
    NATALE, RB
    SESTERHENN, IA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (05): : 350 - 350
  • [46] THROMBOEMBOLIC RISK OF TAMOXIFEN IN PATIENTS WITH STAGE-II BREAST-CANCER
    LEVINE, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (10) : 1579 - 1579
  • [47] IDENTIFICATION OF PATIENTS WITH POOR PROGNOSIS STAGE-II BREAST-CANCER
    OREILLY, SM
    CAMPLEJOHN, RS
    HOWELL, A
    RUBENS, RD
    RICHARDS, MA
    [J]. BRITISH JOURNAL OF CANCER, 1989, 60 (03) : 449 - 449
  • [48] POSTOPERATIVE RADIATION-THERAPY FOR STAGE-II BREAST-CANCER
    TEPMONGKOL, P
    SUPHAPHONGS, N
    CHANTARAKUL, N
    [J]. JOURNAL OF THE MEDICAL ASSOCIATION OF THAILAND, 1983, 66 (08): : 448 - 452
  • [49] DELAYED RECOVERY OF PERIPHERAL-BLOOD CELL NUMBERS AFTER ADJUVANT CYTO-TOXIC CHEMOTHERAPY FOR STAGE-II BREAST-CANCER
    GOODYEAR, MDE
    MACKAY, IR
    RUSSELL, IS
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1981, 7 (01) : 37 - 40
  • [50] WEIGHT-GAIN DURING ADJUVANT CHEMOTHERAPY OR HORMONO-CHEMOTHERAPY FOR STAGE-II BREAST-CANCER EVALUATED IN RELATION TO DISEASE FREE SURVIVAL (DFS)
    BONOMI, P
    BUNTING, N
    FISHMAN, D
    WOLTER, J
    HERNANDEZ, B
    FOLTZ, A
    SHOREY, W
    STRAUS, A
    ANDERSON, K
    ROSEMAN, D
    ECONOMOU, S
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1984, 4 (04) : 339 - 339
12345